354 related articles for article (PubMed ID: 24751833)
1. PPAR-alpha dependent regulation of vanin-1 mediates hepatic lipid metabolism.
van Diepen JA; Jansen PA; Ballak DB; Hijmans A; Hooiveld GJ; Rommelaere S; Galland F; Naquet P; Rutjes FP; Mensink RP; Schrauwen P; Tack CJ; Netea MG; Kersten S; Schalkwijk J; Stienstra R
J Hepatol; 2014 Aug; 61(2):366-72. PubMed ID: 24751833
[TBL] [Abstract][Full Text] [Related]
2. PPARalpha regulates the production of serum Vanin-1 by liver.
Rommelaere S; Millet V; Gensollen T; Bourges C; Eeckhoute J; Hennuyer N; Baugé E; Chasson L; Cacciatore I; Staels B; Pitari G; Galland F; Naquet P
FEBS Lett; 2013 Nov; 587(22):3742-8. PubMed ID: 24140347
[TBL] [Abstract][Full Text] [Related]
3. Novel aspects of PPARalpha-mediated regulation of lipid and xenobiotic metabolism revealed through a nutrigenomic study.
Martin PG; Guillou H; Lasserre F; Déjean S; Lan A; Pascussi JM; Sancristobal M; Legrand P; Besse P; Pineau T
Hepatology; 2007 Mar; 45(3):767-77. PubMed ID: 17326203
[TBL] [Abstract][Full Text] [Related]
4. Sox17 regulates liver lipid metabolism and adaptation to fasting.
Rommelaere S; Millet V; Vu Manh TP; Gensollen T; Andreoletti P; Cherkaoui-Malki M; Bourges C; Escalière B; Du X; Xia Y; Imbert J; Beutler B; Kanai Y; Malissen B; Malissen M; Tailleux A; Staels B; Galland F; Naquet P
PLoS One; 2014; 9(8):e104925. PubMed ID: 25141153
[TBL] [Abstract][Full Text] [Related]
5. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
[TBL] [Abstract][Full Text] [Related]
6. PPARα/γ agonists and antagonists differently affect hepatic lipid metabolism, oxidative stress and inflammatory cytokine production in steatohepatitic rats.
Zhang Y; Cui Y; Wang XL; Shang X; Qi ZG; Xue J; Zhao X; Deng M; Xie ML
Cytokine; 2015 Sep; 75(1):127-35. PubMed ID: 26194065
[TBL] [Abstract][Full Text] [Related]
7. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
[TBL] [Abstract][Full Text] [Related]
8. Activation of peroxisome proliferator-activated receptor alpha by dietary fish oil attenuates steatosis, but does not prevent experimental steatohepatitis because of hepatic lipoperoxide accumulation.
Larter CZ; Yeh MM; Cheng J; Williams J; Brown S; dela Pena A; Bell-Anderson KS; Farrell GC
J Gastroenterol Hepatol; 2008 Feb; 23(2):267-75. PubMed ID: 17868330
[TBL] [Abstract][Full Text] [Related]
9. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
Jia Y; Wu C; Kim J; Kim B; Lee SJ
J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
[TBL] [Abstract][Full Text] [Related]
10. Defect in peroxisome proliferator-activated receptor alpha-inducible fatty acid oxidation determines the severity of hepatic steatosis in response to fasting.
Hashimoto T; Cook WS; Qi C; Yeldandi AV; Reddy JK; Rao MS
J Biol Chem; 2000 Sep; 275(37):28918-28. PubMed ID: 10844002
[TBL] [Abstract][Full Text] [Related]
11. Peroxisome proliferator-activated receptor-α agonist, Wy 14,643, improves metabolic indices, steatosis and ballooning in diabetic mice with non-alcoholic steatohepatitis.
Larter CZ; Yeh MM; Van Rooyen DM; Brooling J; Ghatora K; Farrell GC
J Gastroenterol Hepatol; 2012 Feb; 27(2):341-50. PubMed ID: 21929649
[TBL] [Abstract][Full Text] [Related]
12. Fenofibrate, a peroxisome proliferator-activated receptor alpha agonist, reduces hepatic steatosis and lipid peroxidation in fatty liver Shionogi mice with hereditary fatty liver.
Harano Y; Yasui K; Toyama T; Nakajima T; Mitsuyoshi H; Mimani M; Hirasawa T; Itoh Y; Okanoue T
Liver Int; 2006 Jun; 26(5):613-20. PubMed ID: 16762007
[TBL] [Abstract][Full Text] [Related]
13. Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity.
Stienstra R; Saudale F; Duval C; Keshtkar S; Groener JE; van Rooijen N; Staels B; Kersten S; Müller M
Hepatology; 2010 Feb; 51(2):511-22. PubMed ID: 20054868
[TBL] [Abstract][Full Text] [Related]
14. Nordihydroguaiaretic acid improves metabolic dysregulation and aberrant hepatic lipid metabolism in mice by both PPARα-dependent and -independent pathways.
Zhang H; Shen WJ; Cortez Y; Kraemer FB; Azhar S
Am J Physiol Gastrointest Liver Physiol; 2013 Jan; 304(1):G72-86. PubMed ID: 23104557
[TBL] [Abstract][Full Text] [Related]
15. Enhancement of insulin signaling through inhibition of tissue lipid accumulation by activation of peroxisome proliferator-activated receptor (PPAR) alpha in obese mice.
Ide T; Tsunoda M; Mochizuki T; Murakami K
Med Sci Monit; 2004 Oct; 10(10):BR388-95. PubMed ID: 15448592
[TBL] [Abstract][Full Text] [Related]
16. Fenofibrate, a peroxisome proliferator-activated receptor α ligand, prevents abnormal liver function induced by a fasting-refeeding process.
Lee JN; Dutta RK; Kim SG; Lim JY; Kim SJ; Choe SK; Yoo KW; Song SR; Park DS; So HS; Park R
Biochem Biophys Res Commun; 2013 Dec; 442(1-2):22-7. PubMed ID: 24211584
[TBL] [Abstract][Full Text] [Related]
17. The role and regulation of the peroxisome proliferator activated receptor alpha in human liver.
Kersten S; Stienstra R
Biochimie; 2017 May; 136():75-84. PubMed ID: 28077274
[TBL] [Abstract][Full Text] [Related]
18. Monascin and ankaflavin act as natural AMPK activators with PPARα agonist activity to down-regulate nonalcoholic steatohepatitis in high-fat diet-fed C57BL/6 mice.
Hsu WH; Chen TH; Lee BH; Hsu YW; Pan TM
Food Chem Toxicol; 2014 Feb; 64():94-103. PubMed ID: 24275089
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor alpha mediates the effects of high-fat diet on hepatic gene expression.
Patsouris D; Reddy JK; Müller M; Kersten S
Endocrinology; 2006 Mar; 147(3):1508-16. PubMed ID: 16357043
[TBL] [Abstract][Full Text] [Related]
20. Peroxisome-proliferator-activated receptor-alpha (PPARalpha) deficiency leads to dysregulation of hepatic lipid and carbohydrate metabolism by fatty acids and insulin.
Sugden MC; Bulmer K; Gibbons GF; Knight BL; Holness MJ
Biochem J; 2002 Jun; 364(Pt 2):361-8. PubMed ID: 12023878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
